Skip to content
Capsule Allopathic

Laxana 8 mg capsule

Generic: Lubiprostone

Company: Renata PLC. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength8 mg
PackStrip: 150.00 taka

Reviewed by: not listed yet. Source: not listed yet.

Last updated April 30, 2026.

Compare

Same generic, same strength

Sorted by price per capsule. Ask your pharmacist before you switch brands.

Lubiprostone 8 mg capsules

Prices as listed on BestinMeds.

1 brand listed
Laxana (this medicine)15.00 taka per capsule

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Lubiprostone guide

Indications

Irritable bowel syndrome (IBS) Lubiprostone is indicated in: Irritable Bowel Syndrome with Constipation (IBS-C). Chronic Idiopathic Constipation (CIC) in adults. Opioid-Induced Constipation (OIC) in adult patients with chronic, non-cancer pain.

Dosage and administration

Irritable Bowel Syndrome with Constipation: The recommended dose is 8 mcg twice daily orally with food and water. Dosage in patients with hepatic impairment: Dosage adjustment is not required for patients with moderately impaired hepatic function. For patients with severely impaired hepatic function, the recommended starting dose is 8 mcg once daily. If tolerated then dose can be increased to 8 mcg twice Chronic Idiopathic Constipation and Opioid-induced Constipation: The recommended dose is 24 mcg twice daily orally with food and water. Dosage in patients with hepatic impairment: For patients with moderately impaired hepatic function, the recommended starting dose is 16 mcg twice daily. For patients with severely impaired hepatic function, the recommended starting dose is 8 mcg twice daily.

Side effects

Diarrhea, full or bloated feeling or pressure in the stomach, nausea, stomach pain, swelling of abdominal or stomach area, Dyspnea

Precautions and warnings

Nausea: Patients taking Lubiprostone may experience nausea. Concomitant administration of food with Lubiprostone may reduce symptoms of nausea. Diarrhea: Lubistone should not be prescribed to patients that have severe diarrhea. Bowel Obstruction: In patients with symptoms suggestive of mechanical gastrointestinal obstruction, perform a thorough evaluation to confirm the absence of an obstruction prior to initiating therapy with Lubiprostone.

Pregnancy and lactation

Pregnancy category C. It is not known whether lubiprostone is excreted in human milk. Because lubiprostone increases fluid secretion in the intestine and intestinal motility, human milk-fed infants should be monitored for diarrhea. Caution should be exercised when Lubiprostone is administered to a nursing woman.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250